BOT 2.53% 8.1¢ botanix pharmaceuticals ltd

GW Pharma 's latest quarter revenues came in @ $108m (USD) and...

  1. 1,400 Posts.
    lightbulb Created with Sketch. 560
    GW Pharma 's latest quarter revenues came in @ $108m (USD) and are getting a fair amount of media coverage here in the states,...... wind back the clock three years or so and - for some - it was 'all hype':

    GW Pharmaceuticals Is Terribly Overvalued

    Feb. 21, 2017 11:12 AM ET
    About: GW Pharmaceuticals plc (GWPH), Includes: ZYNE
    This article is exclusive for subscribers.

    GW Pharmaceutical's Epidolex is on track to becoming Americas first FDA approved cannabis-based drug.

    Despite the good news, the company's $3 billion plus enterprise value is unrealistically optimistic.

    Cannabis is not a magic bullet. And the commercial flop of Sativex, GW's first cannabis-based therapy, should serve as a precaution.

    When most people think about investing in Marijuana, they think about seedy OTC pot stocks trading for pennies. However, there are reputable companies in the space. These companies deal with marijuana as a medicinal plant,....

    ....that was then, this is now:

    Q: Given the larger market, could BOT end up in three years time with a MC in the billions?

watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Mkt cap ! $78.82M
Open High Low Value Volume
7.9¢ 8.3¢ 7.8¢ $113.0K 1.410M

Buyers (Bids)

No. Vol. Price($)
3 550736 7.8¢

Sellers (Offers)

Price($) Vol. No.
8.1¢ 14157 1
View Market Depth
Last trade - 16.10pm 12/05/2021 (20 minute delay) ?
0.002 ( 0.77 %)
Open High Low Volume
7.9¢ 8.3¢ 7.8¢ 1075444
Last updated 15.59pm 12/05/2021 (live) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.